Brain injury biomarkers as targets for drugs development and personalized treatment for traumatic brain injury patients.
Saved in:
| Title: | Brain injury biomarkers as targets for drugs development and personalized treatment for traumatic brain injury patients. |
|---|---|
| Authors: | Sandler M; Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Virginia, United States., Almohaish S; Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Virginia, United States.; College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia., Brophy GM; Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Virginia, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 May 26; Vol. 16, pp. 1606174. Date of Electronic Publication: 2025 May 26 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
